Accounts Payable

3 Months Ended

Mar. 31, 2022

Accounts Payable

Accounts Payable

5.            Accounts Payable

As of March 31, 2022, current liabilities included accounts payable of $0.4 million, comprised primarily of amounts owed for drug supply manufacturing of $0.3 million and legal and patent fees of $0.1 million. As of December 31, 2021, current liabilities included accounts payable of $0.1 million, comprised primarily of legal and patent fees and expenses related to manufacturing totaling $0.1 million.